Shane Aaron Johnson Insider Profile
4 Followers
Shane Aaron Johnson, Sr VP & General Manager at Mentari Therapeutics, holds 304.60K shares in Mentari Therapeutics (Ticker: MTRI). Most recently, Shane Aaron Johnson Bought 8,500 shares of Mentari Therapeutics on Jan 06, 2022 for an estimated value of $10.71K.
Shane Aaron Johnson's Trading History
| MTRIMentari Therapeutics | Jan 06, 2022 | Sr VP & General Manager | Informative Buy | 10.71K | $5.67M | |
You May Also Like
Shane Aaron Johnson insider profile FAQ
What is the percentage of profitable transactions made by Shane Aaron Johnson?
The percentage of profitable transactions made by Shane Aaron Johnson is 0%.
What is the average return per transaction made by Shane Aaron Johnson?
The average return per transaction made by Shane Aaron Johnson is -93.50%.
What stocks does Shane Aaron Johnson hold?
Shane Aaron Johnson holds: MTRI stocks.
What was Shane Aaron Johnson’s latest transaction?
Shane Aaron Johnson’s latest transaction was an Informative Buy of $10.71K.
What was Shane Aaron Johnson's most profitable transaction?
Shane Aaron Johnson’s most profitable transaction was an Informative Buy of MTRI stock on November 15, 2021. The return on the trade was -91.70%.
What is Shane Aaron Johnson's role in Mentari Therapeutics?
Shane Aaron Johnson's role in Mentari Therapeutics is Sr VP & General Manager.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
